Revolutionizing Multiple Myeloma Treatment: The Role of Radiomics and AI in FDG PET/CT

Multiple myeloma (MM) is a tricky disease to diagnose and track with imaging. One of the best tools doctors have is FDG PET/CT, but it's not always easy to read the results. The bone marrow can show all sorts of patterns, making it hard for doctors to agree on what they see. This can make it tough to tell how well treatment is working or what the future might hold.Enter radiomics and artificial intelligence (AI). These are new ways to look at images that can help doctors make better decisions. Radiomics can find lots of tiny details in images that might be hard to spot with the naked eye. AI can help make sense of all that data and maybe even spot patterns that humans miss. In the past few years, there's been some exciting work using these tools with FDG PET/CT in MM. Early results are promising, showing that these methods could help make FDG PET/CT readings more standardized and reliable. This could be a big deal for treating MM and helping patients.